Literature DB >> 14522816

Sphingomyelinase activates GLUT4 translocation via a cholesterol-dependent mechanism.

Ping Liu1, Brian J Leffler, Lara K Weeks, Guoli Chen, Christine M Bouchard, Andrew B Strawbridge, Jeffrey S Elmendorf.   

Abstract

A basis for the insulin mimetic effect of sphingomyelinase on glucose transporter isoform GLUT4 translocation remains unclear. Because sphingomyelin serves as a major determinant of plasma membrane cholesterol and a relationship between plasma membrane cholesterol and GLUT4 levels has recently become apparent, we assessed whether GLUT4 translocation induced by sphingomyelinase resulted from changes in membrane cholesterol content. Exposure of 3T3-L1 adipocytes to sphingomyelinase resulted in a time-dependent loss of sphingomyelin from the plasma membrane and a concomitant time-dependent accumulation of plasma membrane GLUT4. Degradation products of sphingomyelin did not mimic this stimulatory action. Plasma membrane cholesterol amount was diminished in cells exposed to sphingomyelinase. Restoration of membrane cholesterol blocked the stimulatory effect of sphingomyelinase. Increasing concentrations of methyl-beta-cyclodextrin, which resulted in a dose-dependent reversible decrease in membrane cholesterol, led to a dose-dependent reversible increase in GLUT4 incorporation into the plasma membrane. Although increased plasma membrane GLUT4 content by cholesterol extraction with concentrations of methyl-beta-cyclodextrin above 5 mM most likely reflected decreased GLUT4 endocytosis, translocation stimulated by sphingomyelinase or concentrations of methyl-beta-cyclodextrin below 2.5 mM occurred without any visible changes in the endocytic retrieval of GLUT4. Furthermore, moderate loss of cholesterol induced by sphingomyelinase or low concentrations of methyl-beta-cyclodextrin did not alter membrane integrity or increase the abundance of other plasma membrane proteins such as the GLUT1 glucose transporter or the transferrin receptor. Regulation of GLUT4 translocation by moderate cholesterol loss did not involve known insulin-signaling proteins. These data reveal that sphingomyelinase enhances GLUT4 exocytosis via a novel cholesterol-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522816     DOI: 10.1152/ajpcell.00073.2003

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  17 in total

1.  Methyl-beta-cyclodextrin suppresses hyaluronan synthesis by down-regulation of hyaluronan synthase 2 through inhibition of Akt.

Authors:  Anne Kultti; Riikka Kärnä; Kirsi Rilla; Pertti Nurminen; Elina Koli; Katri M Makkonen; Jutong Si; Markku I Tammi; Raija H Tammi
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

2.  Chromium picolinate positively influences the glucose transporter system via affecting cholesterol homeostasis in adipocytes cultured under hyperglycemic diabetic conditions.

Authors:  Guruprasad R Pattar; Lixuan Tackett; Ping Liu; Jeffrey S Elmendorf
Journal:  Mutat Res       Date:  2006-07-25       Impact factor: 2.433

Review 3.  Lipid biology of the podocyte--new perspectives offer new opportunities.

Authors:  Alessia Fornoni; Sandra Merscher; Jeffrey B Kopp
Journal:  Nat Rev Nephrol       Date:  2014-05-27       Impact factor: 28.314

4.  AMPK enhances insulin-stimulated GLUT4 regulation via lowering membrane cholesterol.

Authors:  Kirk M Habegger; Nolan J Hoffman; Colin M Ridenour; Joseph T Brozinick; Jeffrey S Elmendorf
Journal:  Endocrinology       Date:  2012-03-20       Impact factor: 4.736

5.  Evidence coupling increased hexosamine biosynthesis pathway activity to membrane cholesterol toxicity and cortical filamentous actin derangement contributing to cellular insulin resistance.

Authors:  Padma Bhonagiri; Guruprasad R Pattar; Kirk M Habegger; Alicia M McCarthy; Lixuan Tackett; Jeffrey S Elmendorf
Journal:  Endocrinology       Date:  2011-06-28       Impact factor: 4.736

Review 6.  Signaling, cytoskeletal and membrane mechanisms regulating GLUT4 exocytosis.

Authors:  Nolan J Hoffman; Jeffrey S Elmendorf
Journal:  Trends Endocrinol Metab       Date:  2011-01-07       Impact factor: 12.015

7.  Niemann-Pick C1-Like 1 deletion in mice prevents high-fat diet-induced fatty liver by reducing lipogenesis.

Authors:  Lin Jia; Yinyan Ma; Shunxing Rong; Jenna L Betters; Ping Xie; Soonkyu Chung; Nanping Wang; Weiqing Tang; Liqing Yu
Journal:  J Lipid Res       Date:  2010-08-10       Impact factor: 5.922

8.  Antidiabetogenic effects of chromium mitigate hyperinsulinemia-induced cellular insulin resistance via correction of plasma membrane cholesterol imbalance.

Authors:  Emily M Horvath; Lixuan Tackett; Alicia M McCarthy; Priya Raman; Joseph T Brozinick; Jeffrey S Elmendorf
Journal:  Mol Endocrinol       Date:  2007-12-28

9.  A novel membrane-based anti-diabetic action of atorvastatin.

Authors:  Emily M Horvath; Lixuan Tackett; Jeffrey S Elmendorf
Journal:  Biochem Biophys Res Commun       Date:  2008-06-02       Impact factor: 3.575

10.  Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice.

Authors:  Eric D Labonté; Lisa M Camarota; Juan C Rojas; Ronald J Jandacek; Dean E Gilham; Joanna P Davies; Yiannis A Ioannou; Patrick Tso; David Y Hui; Philip N Howles
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-08-21       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.